MAXLINEAR INC
MXLNASDAQ🏆 #1008 by market capEarnings Oct 22US Equity
$69.02▲ $0.59 (+0.85%)
Market closed · at close1h—
24h▲ 0.8%
7d▲ 2.2%
14d▲ 20.7%
30d▼ 22.7%
1y▲ 331.9%
🏦Market Cap
$6.26B
Small Cap
📈Revenue Growth (YoY)
+50.5%
High Growth
📊Gross Margin
57.5%
Healthy
💵FCF Margin
2.1%
Thin
⚖️P/S Ratio
11.2x
Elevated
Otter Score
54
Weak
📊
Analyst Ratings
Price
$69.02
Total
17
Raised
3
Lowered
2
Avg PT
$87.50
H / L
$120 / $40
| Institution | Action | Rating | Date |
|---|---|---|---|
Roth Capital | Reiterated | Buy | 2026-07-24 |
Stifel | Reiterated | Buy | 2026-07-24 |
Wells Fargo | Reiterated | Equal Weight | 2026-07-24 |
Susquehanna | Reiterated | Neutral | 2026-07-24 |
Needham | Reiterated | Buy | 2026-07-24 |
Loop Capital | Upgraded | Hold → Buy | 2026-04-29 |
Benchmark | Reiterated | Buy | 2026-01-16 |
Northland Capital Markets | Reiterated | Outperform | 2025-01-06 |
Craig-Hallum | Reiterated | Buy | 2024-10-24 |
Roth MKM | Downgraded | Buy → Neutral | 2023-10-26 |
Deutsche Bank | Downgraded | Buy → Hold | 2023-10-19 |
Exane BNP Paribas | Upgraded | Underperform → Neutral | 2023-05-19 |
JP Morgan | Reiterated | Neutral | 2019-01-04 |
Stifel Nicolaus | Reiterated | Buy | 2018-07-19 |
Topeka | Reiterated | Buy | 2016-02-26 |
JMP Securities | Reiterated | Market Outperform | 2015-07-13 |
Chardan Capital | Upgraded | Neutral → Buy | 2015-06-09 |
One row per institution, most recent rating